Peroxisomal fatty acid metabolism, peroxisomal proliferator-activated receptors and non-alcoholic fatty liver disease

被引：15

作者：

Macdonald, GA ^{[1
]}

Prins, JB ^{[1
]}

机构：

[1] Univ Queensland, Princess Alexandra Hosp, Div Med, Ctr Diabet & Endocrine Res, Brisbane, Qld, Australia

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2004年 / 19卷 / 12期

关键词：

D O I：

10.1111/j.1440-1746.2004.03562.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1335 / 1337

页数：3

共 28 条

[1]

Caldwell SH, 2001, AM J GASTROENTEROL, V96, P519

[2] NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome [J].

Chitturi, S ;

Abeygunasekera, S ;

Farrell, GC ;

Holmes-Walker, J ;

Hui, JM ;

Fung, C ;

Karim, R ;

Lin, R ;

Samarasinghe, D ;

Liddle, C ;

Weltman, M ;

George, J .

HEPATOLOGY, 2002, 35 (02) :373-379

[3] Nonalcoholic fatty liver disease [J].

Clark, JM ;

Brancati, FL ;

Diehl, AM .

GASTROENTEROLOGY, 2002, 122 (06) :1649-1657

[4] The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease [J].

Everett, L ;

Galli, A ;

Crabb, D .

LIVER, 2000, 20 (03) :191-199

[5] Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase -: Implications for peroxisome proliferator-activated receptor α natural ligand metabolism [J].

Fan, CY ;

Pan, J ;

Usuda, N ;

Yeldandi, AV ;

Rao, MS ;

Reddy, JK .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) :15639-15645

[6] Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region? [J].

Farrell, GC .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (02) :124-138

[7]

GARRETT R, 1999, BIOCHEMISTRY-US, P775

[8] Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting [J].

Hashimoto, T ;

Cook, WS ;

Qi, C ;

Yeldandi, AV ;

Reddy, JK ;

Rao, MS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28918-28928

[9]

ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0

[10] Troglitazone prevents fatty changes of the liver in obese diabetic rats [J].

Jia, DM ;

Tabaru, A ;

Akiyama, T ;

Abe, S ;

Otsuki, M .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (10) :1183-1191

← 1 2 3 →